Market Overview:
The global NAC (acetylcisteine) market is expected to register a CAGR of 5.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for nutritional supplements and pharmaceuticals, globally. Additionally, rising awareness about the benefits of NAC is also propelling the growth of this market. Based on type, the global NAC (acetylcisteine) market has been segmented into 98%-99% and above 99%. The 98%-99% segment is expected to account for a major share of the global NAC (acetylcisteine) market in 2018. This can be attributed to its low cost as compared to other types of NAC available in the market. However, with technological advancements being made in this field, manufacturers are offering products with higher purity levels such as above 99%. This is likely to boost the growth of this segment during the forecast period.
 Industry Outlook.svg)
Product Definition:
N-acetylcysteine (NAC) is a prodrug of the amino acid L-cysteine. NAC is used as a mucolytic agent and in the management of chronic obstructive pulmonary disease (COPD). NAC also has antioxidant properties and may be beneficial in the treatment of some psychiatric disorders.
98%-99%:
98%-99% is a range of concentration, which means 98% to 99%. It's basically a mixture of 2-acetylamino-1,3 propanediol. It has the same chemical properties as acrylamide but higher solubility in water and ethanol. Acetylcisteine can be extracted from 98%-99% ethanol solution or it can be synthesized by chemical methods.
It has similar uses.
Above 99%:
Acetylcisteine is a chemical that has antioxidant properties. It is also used in the treatment of cognitive decline associated with aging and dementia. The current research on acetylcisteine indicates that it may be useful in the treatment of brain injuries as well as neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy.
Application Insights:
Nutritional supplements was the leading application segment in 2016, accounting for over 70% of global market share. The product is widely used as a nutritional supplement by athletes and gym-goers to promote muscle endurance and strength. It also helps in improving stamina, mental alertness, and reducing fatigue. These factors are projected to drive the product demand in nutritional supplements applications over the forecast period.
The pharmaceutical segment is expected to witness significant growth with a CAGR of XX% from 2017 to 2030 owing to its wide range of medical applications including treatment for jet lag, cardiovascular diseases (CVDs), gastrointestinal disorders (GITDs), cancer prevention & treatment, osteoporosis management etcetera.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand. The region is expected to maintain its dominance over the forecast period due to increasing health concerns and awareness about nutritional supplements. Asia Pacific is projected to be the fastest-growing regional market from 2018 to 2030 on account of rising product consumption in countries, such as China, Japan, India, and South Korea. Moreover, growing consumer awareness regarding physical fitness will drive industry growth over the coming years.
The European market for global nac consists of major countries including Germany; U.K.; Italy; Spain; and France among others’ In 2016 these countries had a revenue share of approximately 25% amongst Europe’s top 10 pharmaceutical markets which indicates significant growth potential for this region as well considering other emerging sectors such as nutraceuticals & functional foods coupled with bioactive ingredients (Acetyl cisteine).
Growth Factors:
- Increasing prevalence of respiratory diseases and disorders such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis is expected to drive the demand for NAC over the forecast period.
- Rising geriatric population is also a major factor anticipated to fuel the growth of NAC market due to higher susceptibility of this population segment towards respiratory diseases.
- Growing awareness about benefits offered by NAC in prevention and treatment of respiratory conditions is projected to propel its demand in near future.
- Technological advancements in production process are likely to result in reduction of overall cost, thereby making the therapy more affordable for patients across the globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
NAC (Acetylcisteine) Market Research Report
By Type
98%-99%, Above 99%
By Application
Nutritional Supplements, Pharmaceutical, Others
By Companies
Zambon, Nippon Rika, Pharmazell, Kyowa Hakko, Shine Star Biological, Moehs, Chengyi Pharma, Wuhan Grand Hoyo, Donboo Amino Acid, Huachang Pharmaceutical, Xinyi Hanling Biological, Shuguang Biological, Scandinavian Formulas
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global NAC (Acetylcisteine) Market Report Segments:
The global NAC (Acetylcisteine) market is segmented on the basis of:
Types
98%-99%, Above 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Nutritional Supplements, Pharmaceutical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zambon
- Nippon Rika
- Pharmazell
- Kyowa Hakko
- Shine Star Biological
- Moehs
- Chengyi Pharma
- Wuhan Grand Hoyo
- Donboo Amino Acid
- Huachang Pharmaceutical
- Xinyi Hanling Biological
- Shuguang Biological
- Scandinavian Formulas
 Market Overview.svg)
Highlights of The NAC (Acetylcisteine) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 98%-99%
- Above 99%
- By Application:
- Nutritional Supplements
- Pharmaceutical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NAC (Acetylcisteine) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NAC is an acetylcisteine derivative that has been shown to be effective in treating cognitive impairment and dementia. It has also been shown to improve brain function in patients with Alzheimer's disease.
Some of the major companies in the nac (acetylcisteine) market are Zambon, Nippon Rika, Pharmazell, Kyowa Hakko, Shine Star Biological, Moehs, Chengyi Pharma, Wuhan Grand Hoyo, Donboo Amino Acid, Huachang Pharmaceutical, Xinyi Hanling Biological, Shuguang Biological, Scandinavian Formulas.
The nac (acetylcisteine) market is expected to grow at a compound annual growth rate of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. NAC (Acetylcisteine) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. NAC (Acetylcisteine) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. NAC (Acetylcisteine) Market - Supply Chain
4.5. Global NAC (Acetylcisteine) Market Forecast
4.5.1. NAC (Acetylcisteine) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. NAC (Acetylcisteine) Market Size (000 Units) and Y-o-Y Growth
4.5.3. NAC (Acetylcisteine) Market Absolute $ Opportunity
5. Global NAC (Acetylcisteine) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. NAC (Acetylcisteine) Market Size and Volume Forecast by Type
5.3.1. 98%-99%
5.3.2. Above 99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global NAC (Acetylcisteine) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. NAC (Acetylcisteine) Market Size and Volume Forecast by Application
6.3.1. Nutritional Supplements
6.3.2. Pharmaceutical
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global NAC (Acetylcisteine) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. NAC (Acetylcisteine) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global NAC (Acetylcisteine) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. NAC (Acetylcisteine) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global NAC (Acetylcisteine) Demand Share Forecast, 2019-2026
9. North America NAC (Acetylcisteine) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America NAC (Acetylcisteine) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America NAC (Acetylcisteine) Market Size and Volume Forecast by Application
9.4.1. Nutritional Supplements
9.4.2. Pharmaceutical
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America NAC (Acetylcisteine) Market Size and Volume Forecast by Type
9.7.1. 98%-99%
9.7.2. Above 99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America NAC (Acetylcisteine) Demand Share Forecast, 2019-2026
10. Latin America NAC (Acetylcisteine) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America NAC (Acetylcisteine) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America NAC (Acetylcisteine) Market Size and Volume Forecast by Application
10.4.1. Nutritional Supplements
10.4.2. Pharmaceutical
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America NAC (Acetylcisteine) Market Size and Volume Forecast by Type
10.7.1. 98%-99%
10.7.2. Above 99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America NAC (Acetylcisteine) Demand Share Forecast, 2019-2026
11. Europe NAC (Acetylcisteine) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe NAC (Acetylcisteine) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe NAC (Acetylcisteine) Market Size and Volume Forecast by Application
11.4.1. Nutritional Supplements
11.4.2. Pharmaceutical
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe NAC (Acetylcisteine) Market Size and Volume Forecast by Type
11.7.1. 98%-99%
11.7.2. Above 99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe NAC (Acetylcisteine) Demand Share, 2019-2026
12. Asia Pacific NAC (Acetylcisteine) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific NAC (Acetylcisteine) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific NAC (Acetylcisteine) Market Size and Volume Forecast by Application
12.4.1. Nutritional Supplements
12.4.2. Pharmaceutical
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific NAC (Acetylcisteine) Market Size and Volume Forecast by Type
12.7.1. 98%-99%
12.7.2. Above 99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific NAC (Acetylcisteine) Demand Share, 2019-2026
13. Middle East & Africa NAC (Acetylcisteine) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa NAC (Acetylcisteine) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa NAC (Acetylcisteine) Market Size and Volume Forecast by Application
13.4.1. Nutritional Supplements
13.4.2. Pharmaceutical
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa NAC (Acetylcisteine) Market Size and Volume Forecast by Type
13.7.1. 98%-99%
13.7.2. Above 99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa NAC (Acetylcisteine) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global NAC (Acetylcisteine) Market: Market Share Analysis
14.2. NAC (Acetylcisteine) Distributors and Customers
14.3. NAC (Acetylcisteine) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zambon
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Nippon Rika
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pharmazell
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kyowa Hakko
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Shine Star Biological
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Moehs
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Chengyi Pharma
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Wuhan Grand Hoyo
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Donboo Amino Acid
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Huachang Pharmaceutical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Xinyi Hanling Biological
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shuguang Biological
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Scandinavian Formulas
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
